表紙
市場調查報告書

慢性阻塞性肺病 (COPD) 治療藥的全球市場

Chronic Obstructive Pulmonary Disease

出版商 Global Industry Analysts, Inc. 商品編碼 912730
出版日期 內容資訊 英文 159 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
慢性阻塞性肺病 (COPD) 治療藥的全球市場 Chronic Obstructive Pulmonary Disease
出版日期: 2019年10月01日內容資訊: 英文 159 Pages
簡介

本報告提供全球慢性阻塞性肺病 (COPD) 治療藥市場概要,彙整趨勢·發展的影響因素分析,競爭企業與市場佔有率,世界及地區·各主要國家的市場規模的變化與預測,主要企業簡介等資訊。

第1章 簡介·調查手法·調查範圍

第2章 摘要整理

  • 市場概要
    • 全球市場的企業佔有率
    • 全球慢性阻塞性肺病 (COPD) 治療藥市場上企業佔有率方案
  • 主要企業
  • 市場趨勢與發展因素
  • 全球市場預測

第3章 市場分析

  • 各地區市場分析
    • 美國
    • 加拿大
    • 日本
    • 中國
    • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 西班牙
    • 俄羅斯
    • 其他歐洲
    • 亞太地區
    • 澳洲
    • 印度
    • 韓國
    • 其他亞太地區
    • 南美
    • 阿根廷
    • 巴西
    • 墨西哥
    • 其他南美國家
    • 中東
    • 伊朗
    • 以色列
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東
    • 非洲

第4章 競爭企業

  • ASTRAZENECA PLC
  • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
  • CHIESI FARMACEUTICI SPA
  • GLAXOSMITHKLINE PLC
  • MYLAN NV
  • NOVARTIS INTERNATIONAL AG
  • ORION CORPORATION
  • SUNOVION PHARMACEUTICALS
  • TEVA PHARMACEUTICAL INDUSTRIES

第5章 調查資料

目錄
Product Code: MCP-6220

Chronic Obstructive Pulmonary Disease market worldwide is projected to grow by US$6 Billion, driven by a compounded growth of 4.7%. Bronchodilators, one of the segments analyzed and sized in this study, displays the potential to grow at over 5.1%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$5.8 Billion by the year 2025, Bronchodilators will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 3.6% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$212.2 Million to the region's size and clout in the next 5 to 6 years. Over US$174.4 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Bronchodilators will reach a market size of US$255.8 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 7.4% over the next couple of years and add approximately US$1.7 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,, AstraZeneca PLC; Boehringer Ingelheim GmbH; Chiesi Farmaceutici SpA; GlaxoSmithKline PLC; Mylan NV; Novartis International AG; Orion Corporation; Sunovion Pharmaceuticals, Inc.; Teva Pharmaceutical Industries Ltd.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Chronic Obstructive Pulmonary Disease Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Chronic Obstructive Pulmonary Disease Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Chronic Obstructive Pulmonary Disease Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
  • TABLE 3: Chronic Obstructive Pulmonary Disease Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Bronchodilators (Drug Class) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 5: Bronchodilators (Drug Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 6: Bronchodilators (Drug Class) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: Combination (Drug Class) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
  • TABLE 8: Combination (Drug Class) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
  • TABLE 9: Combination (Drug Class) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 10: Phosphodiesterase Type 4 Inhibitors (Drug Class) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
  • TABLE 11: Phosphodiesterase Type 4 Inhibitors (Drug Class) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
  • TABLE 12: Phosphodiesterase Type 4 Inhibitors (Drug Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 13: Mucokinetics (Drug Class) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
  • TABLE 14: Mucokinetics (Drug Class) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 15: Mucokinetics (Drug Class) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 16: Corticosteroids (Drug Class) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 17: Corticosteroids (Drug Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 18: Corticosteroids (Drug Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 19: Other Drug Class (Drug Class) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025
  • TABLE 20: Other Drug Class (Drug Class) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 21: Other Drug Class (Drug Class) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Chronic Obstructive Pulmonary Disease Market Share (in %) by Company: 2019 & 2025
    • TABLE 22: United States Chronic Obstructive Pulmonary Disease Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
    • TABLE 23: Chronic Obstructive Pulmonary Disease Market in the United States by Drug Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 24: United States Chronic Obstructive Pulmonary Disease Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 25: Canadian Chronic Obstructive Pulmonary Disease Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
    • TABLE 26: Canadian Chronic Obstructive Pulmonary Disease Historic Market Review by Drug Class in US$ Million: 2009-2017
    • TABLE 27: Chronic Obstructive Pulmonary Disease Market in Canada: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
  • JAPAN
    • TABLE 28: Japanese Market for Chronic Obstructive Pulmonary Disease: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 29: Chronic Obstructive Pulmonary Disease Market in Japan: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
    • TABLE 30: Japanese Chronic Obstructive Pulmonary Disease Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 31: Chinese Chronic Obstructive Pulmonary Disease Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 32: Chronic Obstructive Pulmonary Disease Historic Market Analysis in China in US$ Million by Drug Class: 2009-2017
    • TABLE 33: Chinese Chronic Obstructive Pulmonary Disease Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • EUROPE
    • Market Facts & Figures
    • European Chronic Obstructive Pulmonary Disease Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 34: European Chronic Obstructive Pulmonary Disease Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 35: Chronic Obstructive Pulmonary Disease Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 36: European Chronic Obstructive Pulmonary Disease Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 37: European Chronic Obstructive Pulmonary Disease Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
    • TABLE 38: Chronic Obstructive Pulmonary Disease Market in Europe in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
    • TABLE 39: European Chronic Obstructive Pulmonary Disease Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 40: Chronic Obstructive Pulmonary Disease Market in France by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 41: French Chronic Obstructive Pulmonary Disease Historic Market Scenario in US$ Million by Drug Class: 2009-2017
    • TABLE 42: French Chronic Obstructive Pulmonary Disease Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
  • GERMANY
    • TABLE 43: Chronic Obstructive Pulmonary Disease Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 44: German Chronic Obstructive Pulmonary Disease Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 45: German Chronic Obstructive Pulmonary Disease Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 46: Italian Chronic Obstructive Pulmonary Disease Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 47: Chronic Obstructive Pulmonary Disease Historic Market Analysis in Italy in US$ Million by Drug Class: 2009-2017
    • TABLE 48: Italian Chronic Obstructive Pulmonary Disease Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED KINGDOM
    • TABLE 49: United Kingdom Market for Chronic Obstructive Pulmonary Disease: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 50: Chronic Obstructive Pulmonary Disease Market in the United Kingdom: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
    • TABLE 51: United Kingdom Chronic Obstructive Pulmonary Disease Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
  • SPAIN
    • TABLE 52: Spanish Chronic Obstructive Pulmonary Disease Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
    • TABLE 53: Spanish Chronic Obstructive Pulmonary Disease Historic Market Review by Drug Class in US$ Million: 2009-2017
    • TABLE 54: Chronic Obstructive Pulmonary Disease Market in Spain: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
  • RUSSIA
    • TABLE 55: Russian Chronic Obstructive Pulmonary Disease Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
    • TABLE 56: Chronic Obstructive Pulmonary Disease Market in Russia by Drug Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 57: Russian Chronic Obstructive Pulmonary Disease Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 58: Rest of Europe Chronic Obstructive Pulmonary Disease Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
    • TABLE 59: Chronic Obstructive Pulmonary Disease Market in Rest of Europe in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
    • TABLE 60: Rest of Europe Chronic Obstructive Pulmonary Disease Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 61: Asia-Pacific Chronic Obstructive Pulmonary Disease Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 62: Chronic Obstructive Pulmonary Disease Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 63: Asia-Pacific Chronic Obstructive Pulmonary Disease Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 64: Chronic Obstructive Pulmonary Disease Market in Asia-Pacific by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 65: Asia-Pacific Chronic Obstructive Pulmonary Disease Historic Market Scenario in US$ Million by Drug Class: 2009-2017
    • TABLE 66: Asia-Pacific Chronic Obstructive Pulmonary Disease Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
  • AUSTRALIA
    • TABLE 67: Chronic Obstructive Pulmonary Disease Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 68: Australian Chronic Obstructive Pulmonary Disease Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 69: Australian Chronic Obstructive Pulmonary Disease Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • INDIA
    • TABLE 70: Indian Chronic Obstructive Pulmonary Disease Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
    • TABLE 71: Indian Chronic Obstructive Pulmonary Disease Historic Market Review by Drug Class in US$ Million: 2009-2017
    • TABLE 72: Chronic Obstructive Pulmonary Disease Market in India: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
  • SOUTH KOREA
    • TABLE 73: Chronic Obstructive Pulmonary Disease Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 74: South Korean Chronic Obstructive Pulmonary Disease Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 75: Chronic Obstructive Pulmonary Disease Market Share Distribution in South Korea by Drug Class: 2009 VS 2019 VS 2025
  • REST OF ASIA-PACIFIC
    • TABLE 76: Rest of Asia-Pacific Market for Chronic Obstructive Pulmonary Disease: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 77: Chronic Obstructive Pulmonary Disease Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
    • TABLE 78: Rest of Asia-Pacific Chronic Obstructive Pulmonary Disease Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
  • LATIN AMERICA
    • TABLE 79: Latin American Chronic Obstructive Pulmonary Disease Market Trends by Region/Country in US$ Million: 2018-2025
    • TABLE 80: Chronic Obstructive Pulmonary Disease Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
    • TABLE 81: Latin American Chronic Obstructive Pulmonary Disease Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
    • TABLE 82: Latin American Chronic Obstructive Pulmonary Disease Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 83: Chronic Obstructive Pulmonary Disease Historic Market Analysis in Latin America in US$ Million by Drug Class: 2009-2017
    • TABLE 84: Latin American Chronic Obstructive Pulmonary Disease Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • ARGENTINA
    • TABLE 85: Argentinean Chronic Obstructive Pulmonary Disease Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
    • TABLE 86: Chronic Obstructive Pulmonary Disease Market in Argentina in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
    • TABLE 87: Argentinean Chronic Obstructive Pulmonary Disease Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • BRAZIL
    • TABLE 88: Chronic Obstructive Pulmonary Disease Market in Brazil by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 89: Brazilian Chronic Obstructive Pulmonary Disease Historic Market Scenario in US$ Million by Drug Class: 2009-2017
    • TABLE 90: Brazilian Chronic Obstructive Pulmonary Disease Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
  • MEXICO
    • TABLE 91: Chronic Obstructive Pulmonary Disease Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 92: Mexican Chronic Obstructive Pulmonary Disease Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 93: Mexican Chronic Obstructive Pulmonary Disease Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • REST OF LATIN AMERICA
    • TABLE 94: Rest of Latin America Chronic Obstructive Pulmonary Disease Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
    • TABLE 95: Chronic Obstructive Pulmonary Disease Market in Rest of Latin America by Drug Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 96: Rest of Latin America Chronic Obstructive Pulmonary Disease Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • MIDDLE EAST
    • TABLE 97: The Middle East Chronic Obstructive Pulmonary Disease Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 98: Chronic Obstructive Pulmonary Disease Market in the Middle East by Region/Country in US$ Million: 2009-2017
    • TABLE 99: The Middle East Chronic Obstructive Pulmonary Disease Market Share Breakdown by Region/Country: 2009, 2019, and 2025
    • TABLE 100: The Middle East Chronic Obstructive Pulmonary Disease Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
    • TABLE 101: The Middle East Chronic Obstructive Pulmonary Disease Historic Market by Drug Class in US$ Million: 2009-2017
    • TABLE 102: Chronic Obstructive Pulmonary Disease Market in the Middle East: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
  • IRAN
    • TABLE 103: Iranian Market for Chronic Obstructive Pulmonary Disease: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 104: Chronic Obstructive Pulmonary Disease Market in Iran: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
    • TABLE 105: Iranian Chronic Obstructive Pulmonary Disease Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
  • ISRAEL
    • TABLE 106: Israeli Chronic Obstructive Pulmonary Disease Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
    • TABLE 107: Chronic Obstructive Pulmonary Disease Market in Israel in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
    • TABLE 108: Israeli Chronic Obstructive Pulmonary Disease Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • SAUDI ARABIA
    • TABLE 109: Saudi Arabian Chronic Obstructive Pulmonary Disease Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 110: Chronic Obstructive Pulmonary Disease Historic Market Analysis in Saudi Arabia in US$ Million by Drug Class: 2009-2017
    • TABLE 111: Saudi Arabian Chronic Obstructive Pulmonary Disease Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED ARAB EMIRATES
    • TABLE 112: Chronic Obstructive Pulmonary Disease Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 113: United Arab Emirates Chronic Obstructive Pulmonary Disease Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 114: Chronic Obstructive Pulmonary Disease Market Share Distribution in United Arab Emirates by Drug Class: 2009 VS 2019 VS 2025
  • REST OF MIDDLE EAST
    • TABLE 115: Chronic Obstructive Pulmonary Disease Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 116: Rest of Middle East Chronic Obstructive Pulmonary Disease Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 117: Rest of Middle East Chronic Obstructive Pulmonary Disease Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • AFRICA
    • TABLE 118: African Chronic Obstructive Pulmonary Disease Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
    • TABLE 119: Chronic Obstructive Pulmonary Disease Market in Africa by Drug Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 120: African Chronic Obstructive Pulmonary Disease Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

IV. COMPETITION

  • ASTRAZENECA PLC
  • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
  • CHIESI FARMACEUTICI SPA
  • GLAXOSMITHKLINE PLC
  • MYLAN NV
  • NOVARTIS INTERNATIONAL AG
  • ORION CORPORATION
  • SUNOVION PHARMACEUTICALS
  • TEVA PHARMACEUTICAL INDUSTRIES

V. CURATED RESEARCH

Back to Top